Jim Cramer Archives - Page 2 of 11

Here's Jim Cramer's Tips for Navigating the Markets During the Iran Conflict

Jim Cramer's advice to investors dealing with the fallout from the US-Israeli attack on Iran: be selective. With stocks initially…

We added a new Bullpen name during Friday's monthly meeting, and it has minimal economic sensitivity and faces little to…

Danaher's days in the portfolio may be numbered. We were once again disappointed after Danaher's latest acquisition plan failed to…

Danaher shares fell Wednesday as Wall Street failed to give the supplier of tools and equipment to drugmakers and hospitals…

Bristol Myers Squibb and Microsoft's new partnership aimed at accelerating the early detection of lung cancer marks the latest way…

Jim Cramer says not to worry about Novo Nordisk's lead over Club that has Eli Lilly in the obesity pill…

Danaher is finally turning the corner. CNBC's Jim Cramer sees it. Wall Street does it too. Life sciences stocks are…

Life sciences stocks are experiencing a resurgence, and that's good news for Danaher. Connecting the dots with better times ahead…

Eli Lilly shares rose Thursday after the drugmaker posted a strong third quarter, boosted by sales of its popular GLP-1…

Shares of Abbott Laboratories fell 3% on Wednesday after the diversified healthcare company turned in another less-than-stellar quarter. Revenue in…